| Literature DB >> 28441528 |
Nicole A J Krentz1, Dennis van Hoof2, Zhongmei Li2, Akie Watanabe1, Mei Tang1, Cuilan Nian1, Michael S German3, Francis C Lynn4.
Abstract
During pancreatic development, proliferating pancreatic progenitors activate the proendocrine transcription factor neurogenin 3 (NEUROG3), exit the cell cycle, and differentiate into islet cells. The mechanisms that direct robust NEUROG3 expression within a subset of progenitor cells control the size of the endocrine population. Here we demonstrate that NEUROG3 is phosphorylated within the nucleus on serine 183, which catalyzes its hyperphosphorylation and proteosomal degradation. During progression through the progenitor cell cycle, NEUROG3 phosphorylation is driven by the actions of cyclin-dependent kinases 2 and 4/6 at G1/S cell-cycle checkpoint. Using models of mouse and human pancreas development, we show that lengthening of the G1 phase of the pancreatic progenitor cell cycle is essential for proper induction of NEUROG3 and initiation of endocrine cell differentiation. In sum, these studies demonstrate that progenitor cell-cycle G1 lengthening, through its actions on stabilization of NEUROG3, is an essential variable in normal endocrine cell genesis.Entities:
Keywords: CRISPR/Cas9; Cdkn1b; G1 lengthening; Kras; Ngn3; Sox9-rTTA; diabetes; human embryonic stem cells; insulin; mouse
Mesh:
Substances:
Year: 2017 PMID: 28441528 PMCID: PMC5517315 DOI: 10.1016/j.devcel.2017.02.006
Source DB: PubMed Journal: Dev Cell ISSN: 1534-5807 Impact factor: 12.270